Gopi M. VENKATESH,Micael GUILLOT,Jin-Wang LAI,Michael GOSSELIN,Nicole A. BEINBORN
申请号：
US14445949
公开号：
US20150030676A1
申请日:
2014.07.29
申请国别(地区):
US
年份:
2015
代理人:
摘要：
This invention relates to an oral stabilized modified release pharmaceutical dosage form containing L-methylfolate calcium, which is primarily absorbed from proximal small intestine via a saturable human proton-coupled folate transporter (h-PCFT) mediated transport intended as monotherapy for the treatment of patients with MDDs and/or diagnosed with dysthymia, schizophrenia, or degenerative dementia of the Alzheimer type.
